Gastrointestinal Endoscopy Excellence Center and Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand; Division of Gastroenterology, Department of Medicine, Bangkok, Thailand.
Gastrointestinal Endoscopy Excellence Center and Center of Excellence for Innovation and Endoscopy in Gastrointestinal Oncology, Department of Medicine, King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
Gastrointest Endosc. 2023 Mar;97(3):507-516. doi: 10.1016/j.gie.2022.09.023. Epub 2022 Oct 8.
BACKGROUND AND AIMS: Computer-aided detection (CADe) and a mucosal exposure device can improve adenoma detection rate (ADR). Potential benefits of combining the 2 modalities have never been studied. This study aimed to compare ADR differences among CADe alone, endocuff-assisted colonoscopy (EAC) alone, and the combination of CADe and EAC (CADe+EAC) with standard colonoscopy. METHODS: This prospective randomized controlled study included 1245 participants who underwent screening colonoscopy. Participants were randomized to CADe, EAC, CADe+EAC, and standard colonoscopy as a control. The primary outcome was ADR. Secondary outcomes were proximal ADR (pADR), advanced ADR (AADR), and the number of adenomas per colonoscopy (APCs). RESULTS: ADRs from the control, CADe, EAC, and CADe+EAC groups were 41.9%, 52.2%, 54.0%, and 58.8%, respectively; pADRs were 25.2%, 33.3%, 34.9%, and 37.0%, respectively; AADRs were 7.7%, 8.3%, 8.3%, and 13.6%, respectively; and APCs were .76, 1.11, 1.18, and 1.31, respectively. Significant increases in ADR and pADR were observed between the intervention and control groups (P < .05 in all comparisons). The AADR was significantly higher only in the CADe+EAC group than in the control group (P = .02). The adjusted incidence rate ratios of APCs were significantly higher in the intervention groups versus the control group (P < .01 in all comparisons). CONCLUSIONS: CADe+EAC significantly improve ADR and AADR over standard colonoscopy. However, although CADe or EAC alone can substantially increase the detection of adenomas, they do not lead to increased detection of advanced adenomas unless used in combination. (Clinical trial registration number: TCTR20200929003.).
背景与目的:计算机辅助检测 (CADe) 和黏膜暴露装置可提高腺瘤检出率 (ADR)。联合使用这两种方法的潜在益处尚未得到研究。本研究旨在比较 CADe 单独、内镜辅助结肠检查 (EAC) 单独和 CADe 联合 EAC(CADe+EAC)与标准结肠镜检查之间的 ADR 差异。
方法:这是一项前瞻性随机对照研究,纳入了 1245 名接受筛查性结肠镜检查的参与者。参与者被随机分配至 CADe、EAC、CADe+EAC 和标准结肠镜检查(对照组)。主要结局是 ADR。次要结局是近端 ADR(pADR)、高级 ADR(AADR)和每例结肠镜检查的腺瘤数(APCs)。
结果:对照组、CADe 组、EAC 组和 CADe+EAC 组的 ADR 分别为 41.9%、52.2%、54.0%和 58.8%;pADR 分别为 25.2%、33.3%、34.9%和 37.0%;AADR 分别为 7.7%、8.3%、8.3%和 13.6%;APC 分别为.76、1.11、1.18 和 1.31。干预组与对照组相比,ADR 和 pADR 均显著增加(所有比较均 P<.05)。仅 CADe+EAC 组的 AADR 显著高于对照组(P=.02)。干预组的 APC 调整发病率比显著高于对照组(所有比较均 P<.01)。
结论:CADe+EAC 可显著提高标准结肠镜检查的 ADR 和 AADR。然而,虽然 CADe 或 EAC 单独使用可以大大提高腺瘤的检出率,但除非联合使用,否则不会导致高级腺瘤的检出率增加。(临床试验注册号:TCTR20200929003。)
Gastroenterology. 2020-8
World J Gastroenterol. 2019-3-7
World J Gastrointest Endosc. 2025-8-16
Cancers (Basel). 2025-2-26